Purchase Short-Term Access

Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?
Daniel S. Budnitz, MD, MPH; Nadine Shehab, PharmD; Scott R. Kegler, PhD; Chesley L. Richards, MD, MPH
Annals of Internal Medicine 2008;148:629. doi:10.7326/0003-4819-148-8-200804150-00018

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.